Molecular mechanisms controlling chemokine receptor mrna stability

Project Information

Grant agreement ID: QLG1-CT-1999-51520

Project closed

Start date 1 September 2000

End date 31 August 2002

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 0,00

EU contribution No data

Coordinated by

MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH
Italy

Objective

mRNA stability is a major checkpoint for the expression of certain chemokine receptors, affecting leukocyte recruitment in sites of infection, tumours and inflammatory diseases. The project aim is to investigate how CCR2mRNA half-life is regulated and how this influence CCR2 gene expression. mRNA stability is a major checkpoint for the expression of certain chemokine receptors, affecting leukocyte recruitment in sites of infection, tumours and inflammatory diseases. The project aim is to investigate how CCR2mRNA half-life is regulated and how this influence CCR2 gene expression.

Fields of science

• medical and health sciences › health sciences › inflammatory diseases

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH

• EU contribution: No data
• Address: Via Eritrea 62 ; 20157 MILANO ; Italy
• Total cost: No data